But just 5 years after an affordable meningitis A vaccine was introduced, its use has led to the control and near elimination of deadly meningitis A disease in the African meningitis belt
extending all over the continent from Senegal to Ethiopia.
org/) has been widely introduced to at-risk areas in the meningitis belt
, resulting in a change in the epidemiology of meningococcal meningitis in the region (1,2).
Those arriving from nations of the African Meningitis Belt
- including the Gambia, Senegal, Guinea-Bissau, Guinea, Mali, Burkina Faso, Ghana, Niger, Nigeria, Cameroon, Chad, Central African Republic, Sudan, South Sudan, Uganda, Kenya, Ethiopia, Eritrea - will be also be obliged to receive a preventive vaccine upon entry into Saudi Arabia.
Menveo pricing (Western markets) Nimenrix pricing (Western markets) ACWY-Vax pricing (Western markets) Menactra pricing (ROW markets) Menveo pricing (ROW markets) AWCY-Vax pricing (ROW markets) Menactra & Menveo pricing trends: US Model caveats and limitations Country focus Africa Africa: the meningitis belt
Africa: MenAfriVac roll-out plan Africa: Future dynamics Bibliography About VacZine Analytics Disclaimer PAGES: 85 MS PowerPoint slides, fully referenced/sourced.
The ministry, in February last year, declared the young nation, which lies in Africa's Meningitis belt
, free from the bacterial disease.
The African meningitis belt
extends from Ethiopia to Senegal and has cyclical epidemics occurring every 5 - 10 years, resulting in attack rates of 1 000/100 000 or higher.
A large section of Africa is known as the Meningitis Belt
because of the severity of meningitis epidemics there.
Frequent travelers to or people living in areas with high rates of meningococcal disease, such as the African meningitis belt
meningitidis often strike Africa's so-called meningitis belt
, which stretches from Senegal to Ethiopia.
From December through June, however, meningococcal vaccine is still recommended for travel to countries in Africa's meningitis belt
To detect epidemics, national routine surveillance of suspected cases of acute bacterial meningitis has been conducted in all meningitis belt
countries according to World Health Organization (WHO) guidelines (1), although the recommendation of splitting large districts (>100,000 inhabitants) into subdistricts is not always followed.
Nonetheless, there is need for political commitment in meningitis belt
countries in Africa to contain the disease, it quoted Jean Marie Okeo-Bele, WHO Director of the Department of Immunisation, Vaccines and Biological to have said.